Drug recall
Bella Capsules, 600mg, 30-count bottles, Manufactured for: Bella All Natural 304 E 11th Street, Los Angeles…
FDA recall event 79327 · Class I · Bella All Natural
Key facts
| Event ID | 79327 |
|---|---|
| Recall numbers | D-0593-2018 |
| Recalling firm | Bella All Natural |
| Product type | Drugs |
| Products | Bella Capsules, 600mg, 30-count bottles, Manufactured for: Bella All Natural 304 E 11th Street, Los Angeles, CA 90015 |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Marketed Without An Approved NDA/ANDA: This product contains undeclared sibutramine. The presence of sibutramine, a previously approved controlled substance that was withdrawn from the U.S. market in… |
| Initiation date | Feb 14, 2018 |
| Report date | Mar 14, 2018 |
| Termination date | Jan 28, 2019 |
| City | Los Angeles |
| State | CA |
| Country | United States |
| FEI number | 3012416471 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: